Maya Martinez-Davis


Maya Martinez-Davis joined GSK in September 2019 to lead the $20B+ pharmaceuticals and vaccines businesses in the US and Puerto Rico as President, US Pharmaceuticals, effective January 1, 2020.

Previously she served as president of the Biopharma Latin America business for Merck KGaA, Darmstadt, Germany. Maya used her proven expertise driving ph...

Roles at Mirati Therapeutics

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.